Venus Remedies surges 6% after getting marketing nod for lung cancer drug

Quick Summary:

By comparison, the BSE Sensex was down 0.02 per cent at 81,729.23 level.

The company has a total market capitalisation of Rs 458.42 crore.

The company is one of the major global manufacturers of critical care antibiotics, such as meropenem and imipenem-cilastatin.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaPhilippines

Topics: Buzzing stocks Venus Remedies Venus Remedies shares Venus Remedies share price Venus Remedies share price today Stock market Venus Remedies news Venus Remedies share price Sensex

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-12-09 @ 11:59:55 (2 weeks ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 339 words

Reading Time: 2 minutes read

Sentences: 14 lines

Sentence Length: 25 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 24262945

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 197 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions